Arrowstreet Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-40,211
Closed -$1.27M – 2098
2026
Q1
$1.27M Buy
+40,211
New +$1.27M ﹤0.01% 1502
2025
Q2
– Sell
-282,275
Closed -$6.46M – 2065
2025
Q1
$6.46M Buy
+282,275
New +$6.81M 0.01% 944
2024
Q3
– Sell
-20,381
Closed -$604K – 1852
2024
Q2
$604K Sell
20,381
-99,416
-83% -$2.76M ﹤0.01% 1309
2024
Q1
$3.61M Buy
119,797
+97,060
+427% +$2.69M ﹤0.01% 984
2023
Q4
$651K Buy
+22,737
New +$668K ﹤0.01% 1182
2023
Q2
– Sell
-26,043
Closed -$951K – 1447
2023
Q1
$951K Buy
+26,043
New +$822K ﹤0.01% 1076

Other funds holding RTO

Arrowstreet Capital's RTO Position: Q2 2026 in Review

Arrowstreet Capital sold out of Rentokil (RTO) in Q2 2026, closing a stake of 40,211 shares — an estimated $1.27M sold.

Arrowstreet Capital first reported a position in RTO in Q1 2023 and held it in 6 quarters. The position peaked at $6.46M in Q1 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Arrowstreet Capital reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 40,211 Rentokil shares in Q2 2026, an estimated $1.27M.
  • Arrowstreet Capital first reported a position in Rentokil in Q1 2023 and held it in 6 quarters.
  • Arrowstreet Capital's Rentokil position peaked at $6.46M in Q1 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.